Medicare Benefit Policy Manual (Pub. 100-02), Ch. 14 § 20.3
FDA Withdrawal of IDE Approval or Change in Categorization
20.3 - FDA Withdrawal of IDE Approval or Change in Categorization
(Rev. 198, Issued: 11-06-14, Effective: 01-01-15, Implementation: 01-05-15)
If the FDA becomes aware that a categorized device no longer meets certain
requirements and a sponsor (e.g., a manufacturer) loses its Category B status, or violates
relevant IDE requirements necessitating FDA’s withdrawal of IDE approval, all payment
for the device and related routine care items and services should cease. The CMS master
file and CMS Coverage Website will be updated to reflect withdrawals of FDA IDE
approvals and categorization changes, as appropriate.